Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
Public ClinicalTrials.gov record NCT02736656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of SPN-812 for the Treatment of Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients
Study identification
- NCT ID
- NCT02736656
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 4 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2, 2016 (Actual)
- Primary completion
- Sep 2026 (Estimated)
- Completion
- Sep 2026 (Estimated)
- Last update posted
- Jul 15, 2026
2016 – 2026
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Alliance for Wellness dba Alliance for Research | Long Beach | California | 90807 | — |
| MCB Clinical Research Centers, LLC | Colorado Springs | Colorado | 80910 | — |
| Meridien Research at Florida Clinical Research Center | Bradenton | Florida | 34201 | — |
| Sarkis Clinical Trials | Gainesville | Florida | 32607 | — |
| Indago Research & Health Center, Inc. | Hialeah | Florida | 33012 | — |
| Florida Clinical Research Center, LLC. | Maitland | Florida | 32751 | — |
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
| IPS Research | Oklahoma City | Oklahoma | 73103 | — |
| Paradigm Research Professionals | Oklahoma City | Oklahoma | 73118 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| CNS Healthcare | Memphis | Tennessee | 38119 | — |
| Bayou City Research Corporation | Houston | Texas | 77006 | — |
| Road Runner Research | San Antonio | Texas | 78258 | — |
| Ericksen Research & Development | Clinton | Utah | 84015 | — |
| Northwest Clinical Trials | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02736656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02736656 live on ClinicalTrials.gov.